Evidence map›Paper›PMID 25401747›Full record

ArticlePloS one2014

Deep sequencing of HIV-1 near full-length proviral genomes identifies high rates of BF1 recombinants including two novel circulating recombinant forms (CRF) 70_BF1 and a disseminating 71_BF1 among blood donors in Pernambuco, Brazil.

Rodrigo Pessôa, Jaqueline Tomoko Watanabe, Paula Calabria, Alvina Clara Felix, Paula Loureiro, Ester C Sabino, Michael P Busch, Sabri S Sanabani, International Component of the NHLBI Recipient Epidemiology and Donor Evaluation Study-III

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Human Immunodeficiency Virus (HIV).Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Rodrigo PessôaVirology Department, São Paulo Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil.
Jaqueline Tomoko WatanabeVirology Department, São Paulo Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil.
Paula CalabriaVirology Department, São Paulo Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil.
Alvina Clara FelixVirology Department, São Paulo Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil.
Paula LoureiroPernambuco State Center of Hematology and Hemotherapy, Recife, Pernambuco, Brazil.
Ester C SabinoDepartment of Infectious Disease/Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil.
Michael P BuschBlood Systems Research Institute, San Francisco, California, United States of America.
Sabri S SanabaniClinical Laboratory, Department of Pathology, Hospital das Clínicas, School of Medicine, University of São Paulo, São Paulo, Brazil.
International Component of the NHLBI Recipient Epidemiology and Donor Evaluation Study-III
Universidade de São Paulo · BRBlood Systems Research Institute · USHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BR

Funding

NHLBI NIH HHS HHSN268200417175CNHLBI NIH HHS HHSN268201100007CNHLBI NIH HHS HHSN268201100007IODCDC CDC HHS HHSN268200417175C
6 · The paper itself

Abstract

backgroundThe findings of frequent circulation of HIV-1 subclade F1 viruses and the scarcity of BF1 recombinant viruses based on pol subgenomic fragment sequencing among blood donors in Pernambuco (PE), Northeast of Brazil, were reported recently. Here, we aimed to determine whether the classification of these strains (n = 26) extends to the whole genome sequences.

methodsFive overlapping amplicons spanning the HIV near full-length genomes (NFLGs) were PCR amplified from peripheral blood mononuclear cells (PBMCs) of 26 blood donors. The amplicons were molecularly bar-coded, pooled, and sequenced by Illumina paired-end protocol. The prevalence of viral variants containing drug resistant mutations (DRMs) was compared between plasma and PBMCs.

resultsOf the 26 samples studied, 20 NFLGs and 4 partial fragments were de novo assembled into contiguous sequences and successfully subtyped. Two distinct BF1 recombinant profiles designated CRF70_BF1 and CRF71_BF1, with 4 samples in profile I and 11 in profile II were detected and thus constitute two novel recombinant forms circulating in PE. Evidence of dual infections was detected in four patients co-infected with distinct HIV-1 subtypes. According to our estimate, the new CRF71_BF1 accounts for 10% of the HIV-1 circulating strains among blood donors in PE. Discordant data between the plasma and PBMCs-virus were found in 15 of 24 donors. Six of these strains displayed major DRMs only in PBMCs and four of which had detectable DRMs changes at prevalence between 1-20% of the sequenced population.

conclusionsThe high percentage of the new RF71_BF1 and other BF1 recombinants found among blood donors in Pernambuco, coupled with high rates of transmitted DRMs and dual infections confirm the need for effective surveillance to monitor the prevalence and distribution of HIV variants in a variety of settings in Brazil.

Indexed as

Blood DonorsGenome, ViralProvirusesRecombination, GeneticBrazilDrug Resistance, ViralGenotypeHigh-Throughput Nucleotide SequencingHIV-1HIV InfectionsHumansMolecular Sequence DataMutationPhylogenyReassortant Viruses

Identifiers

PMID25401747
PMCPMC4234413
OpenAlexW2093566116

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.